# Reduction of Bacteria in MRSA Positive Ulcers

> **NCT00771368** · PHASE1,PHASE2 · TERMINATED · sponsor: **Nitric BioTherapeutics, Inc** · enrollment: 20 (estimated)

## Conditions studied

- Leg Ulcer
- Pressure Ulcer

## Interventions

- **DRUG:** Nitric Oxide

## Key facts

- **NCT ID:** NCT00771368
- **Lead sponsor:** Nitric BioTherapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2009-05
- **Final completion:** 2009-06
- **Target enrollment:** 20 (ESTIMATED)
- **Why stopped:** limited recruitment
- **Last updated:** 2012-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00771368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00771368, "Reduction of Bacteria in MRSA Positive Ulcers". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00771368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*